VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_24-vv-00070
Package ID: USCOURTS-cofc-1_24-vv-00070
Petitioner: Thomas Dido, Sr.
Filed: 2024-01-18
Decided: 2026-01-05
Vaccine: influenza; Tdap; pneumococcal conjugate (PCV20)
Vaccination date: 2023-01-06
Condition: chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and/or myopathy
Outcome: compensated
Award amount USD: 120000

AI-assisted case summary:
Thomas Dido, Sr. filed his petition on January 18, 2024, alleging that vaccines administered on January 6, 2023 caused chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, and/or myopathy. The covered vaccines identified in the decision were influenza, tetanus-diphtheria-acellular pertussis (Tdap), and pneumococcal conjugate (PCV20) vaccines. The decision also notes that he received a non-covered zoster vaccine the same day.

Respondent denied that the flu, Tdap, and/or PCV20 vaccines caused Mr. Dido's alleged injuries and denied that the vaccines caused any other injury or current disability. The public stipulation does not describe his first neurologic symptom, weakness pattern, eye or bulbar symptoms, diagnostic testing, EMG or nerve conduction findings, antibody testing, imaging, hospitalization, IVIG or steroid treatment, or long-term functional limitations.

The available public story is therefore a settlement record rather than a medical narrative: Mr. Dido attributed a serious neuromuscular illness to three covered vaccines administered on January 6, 2023; respondent denied causation; and the parties resolved the disputed claim by stipulation. Special Master Nora Beth Dorsey found the stipulation reasonable and adopted it on January 5, 2026. He received $120,000.00 as a lump sum through counsel's IOLTA account.

Theory of causation field:
Influenza, Tdap, and PCV20 vaccines on January 6, 2023, with non-covered zoster vaccine also received; alleged CIDP, myasthenia gravis, and/or myopathy. COMPENSATED by stipulation. Respondent denied causation. Public stipulation lacks clinical chronology, diagnostics, treatment, experts, or mechanism. SM Dorsey January 5, 2026. Award $120,000.00 lump sum. Petition filed January 18, 2024.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_24-vv-00070-0
Date issued/filed: 2026-01-30
Pages: 8
Docket text: PUBLIC DECISION (Originally filed: 1/5/2026) regarding 58 DECISION Stipulation. Signed by Special Master Nora Beth Dorsey. (aevw) Service on parties made. (Main Document 62 replaced on 2/2/2026 to correct double header.) (fm).
--------------------------------------------------------------------------------
Case 1:24-vv-00070-UNJ Document 62 Filed 01/30/26 Page 1 of 8
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: January 5, 2026
* * * * * * * * * * * * * * * * * * *
THOMAS DIDO, SR., * UNPUBLISHED
*
Petitioner, * No. 24-70V
*
v. * Special Master Dorsey
*
SECRETARY OF HEALTH * Decision Based on Stipulation; Influenza
AND HUMAN SERVICES, * (“Flu”) Vaccine; Tetanus, Diphtheria, and
* Acellular Pertussis (“Tdap”) Vaccine;
Respondent. * Pneumococcal Conjugate (“PCV20”)
* Vaccine; Chronic Inflammatory
* Demyelinating Polyneuropathy (“CIDP”);
* * * * * * * * * * * * * * * * * * * Myasthenia Gravis; Myelopathy.
Elizabeth Kyla Abramson, Mctlaw, Washington, DC, for Petitioner.
Irene Angelica Firippis, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION BASED ON STIPULATION1
On January 18, 2024, Thomas Dido, Sr., (“Petitioner”) filed a petition in the National
Vaccine Injury Program2 alleging that he suffered from chronic inflammatory demyelinating
polyneuropathy (“CIDP”), myasthenia gravis, and/or myopathy following the administration of
1 Because this Decision contains a reasoned explanation for the action in this case, the
undersigned is required to post it on the United States Court of Federal Claims’ website and/or at
https://www.govinfo.gov/app/collection/uscourts/national/cofc in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of
Electronic Government Services). This means the Decision will be available to anyone with
access to the Internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to
identify and move to redact medical or other information, the disclosure of which would
constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the
identified material fits within this definition, the undersigned will redact such material from
public access.
2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National
Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended,
42 U.S.C. §§ 300aa-10 to -34 (2018) (“Vaccine Act” or “the Act”). All citations in this Decision
to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.
1

Case 1:24-vv-00070-UNJ Document 62 Filed 01/30/26 Page 2 of 8
an influenza (“flu”) vaccine, a tetanus, diphtheria, and acellular pertussis (“Tdap”) vaccine, and a
pneumococcal conjugate (“PCV20”) vaccine on January 6, 2023.3 Petition at 1, 9 (ECF No. 1).
On January 5, 2026, the parties filed a stipulation recommending an award of
compensation to Petitioner. Stipulation (ECF No. 57). Respondent denies that the flu vaccine,
Tdap vaccine, and/or PCV20 vaccine caused Petitioner’s alleged injuries and denies that the
vaccines caused any other injury or Petitioners current disabilities. Nevertheless, the parties
agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the
stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the
terms set forth therein.
The parties stipulate that Petitioner shall receive the following compensation:
(1) A lump sum of $120,000.00 to be paid through an ACH deposit to Petitioner’s
counsel’s IOLTA account for prompt disbursement to Petitioner.
This amount represents compensation for all damages that would be available under 42
U.S.C. § 300aa-15(a). Stipulation at ¶ 8.
The undersigned approves the requested amount for Petitioner’s compensation.
Accordingly, an award should be made consistent with the stipulation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.4
IT IS SO ORDERED.
s/Nora B. Dorsey
Nora B. Dorsey
Special Master
3 Petitioner also received a non-covered zoster vaccine on January 6, 2023.
4 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of
notice renouncing the right to seek review.
2

Case 1:24-vv-00070-UNJ Document 62 Filed 01/30/26 Page 3 of 8

Case 1:24-vv-00070-UNJ Document 62 Filed 01/30/26 Page 4 of 8

Case 1:24-vv-00070-UNJ Document 62 Filed 01/30/26 Page 5 of 8

Case 1:24-vv-00070-UNJ Document 62 Filed 01/30/26 Page 6 of 8

Case 1:24-vv-00070-UNJ Document 62 Filed 01/30/26 Page 7 of 8

Case 1:24-vv-00070-UNJ Document 62 Filed 01/30/26 Page 8 of 8